Lack of effect of oral N-acetylcysteine on the acute dialysis-related lowering of total plasma homocysteine in hemodialysis patients
- 29 February 1996
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 120 (1-2) , 241-244
- https://doi.org/10.1016/0021-9150(95)05705-6
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patientsKidney International, 1996
- Serum Total Homocysteine and Coronary Heart DiseaseInternational Journal of Epidemiology, 1995
- Net uptake of plasma homocysteine by the rat kidney in vivoAtherosclerosis, 1995
- Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control studyAtherosclerosis, 1995
- Short term betaine therapy fails to lower elevated fasting total plasma homocysteine concentrations in hemodialysis patients maintained on chronic folic acid supplementationAtherosclerosis, 1995
- Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery StenosisNew England Journal of Medicine, 1995
- High dose ascorbate supplementation fails to affect plasma homocyst(e)ine levels in patients with coronary heart diseaseAtherosclerosis, 1994
- Plasma homocysteine and thiol compound fractions after oral administration of N-acetylcysteineScandinavian Journal of Clinical and Laboratory Investigation, 1994
- A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physiciansPublished by American Medical Association (AMA) ,1992
- Clinical Pharmacokinetics of N-AcetylcysteineClinical Pharmacokinetics, 1991